volume 726 pages 144132

Role of the NF-κB signaling pathway in the pathogenesis of colorectal cancer

Atena Soleimani 1, 2
Farzad Rahmani 1
Gordon A Ferns 3
Mikhail Ryzhikov 4
Amir Avan 5
Seyed Isaac Hashemy 6
Publication typeJournal Article
Publication date2020-02-01
scimago Q2
wos Q3
SJR0.682
CiteScore5.1
Impact factor2.4
ISSN03781119, 18790038
General Medicine
Genetics
Abstract
• Over-activation of the NF-κB pathway is a feature of CRC. • Suppression of the NF-κB signaling pathway is a potential therapeutic approach in the treatment of CRC. • This review summarizes the regulatory role of NF-κB signaling pathway in the pathogenesis of CRC. The NF-κB signaling pathway is a key regulator of CRC cell proliferation, apoptosis, angiogenesis, inflammation, metastasis, and drug resistance. Over-activation of the NF-κB pathway is a feature of colorectal cancer (CRC). While new combinatorial treatments have improved overall patient outcome; quality of life, cost of care, and patient survival rate have seen little improvement. Suppression of the NF-κB signaling pathway using biological or specific pharmacological inhibitors is a potential therapeutic approach in the treatment of colon cancer. This review summarizes the regulatory role of NF-κB signaling pathway in the pathogenesis of CRC for a better understanding and hence a better management of the disease.
Found 
Found 

Top-30

Journals

2
4
6
8
10
12
14
International Journal of Molecular Sciences
14 publications, 7.91%
Frontiers in Oncology
7 publications, 3.95%
Frontiers in Pharmacology
5 publications, 2.82%
Molecules
4 publications, 2.26%
Scientific Reports
3 publications, 1.69%
Journal of Functional Foods
3 publications, 1.69%
Journal of Cellular and Molecular Medicine
3 publications, 1.69%
International Journal of Molecular Medicine
3 publications, 1.69%
Biomedicines
2 publications, 1.13%
Cancers
2 publications, 1.13%
Frontiers in Immunology
2 publications, 1.13%
Medical Oncology
2 publications, 1.13%
Biochimica et Biophysica Acta - Reviews on Cancer
2 publications, 1.13%
Biomedicine and Pharmacotherapy
2 publications, 1.13%
European Journal of Pharmacology
2 publications, 1.13%
Cell Death and Disease
2 publications, 1.13%
Pharmaceutical Biology
2 publications, 1.13%
Evidence-based Complementary and Alternative Medicine
2 publications, 1.13%
Chemico-Biological Interactions
2 publications, 1.13%
Pharmaceuticals
2 publications, 1.13%
Pathology Research and Practice
2 publications, 1.13%
Cancer Research Communications
2 publications, 1.13%
Translational Oncology
2 publications, 1.13%
Biological and Pharmaceutical Bulletin
1 publication, 0.56%
Chinese Medicine
1 publication, 0.56%
American Journal of Chinese Medicine
1 publication, 0.56%
BioFactors
1 publication, 0.56%
Journal of International Medical Research
1 publication, 0.56%
Non-coding RNA
1 publication, 0.56%
2
4
6
8
10
12
14

Publishers

5
10
15
20
25
30
35
40
45
Elsevier
42 publications, 23.73%
MDPI
32 publications, 18.08%
Springer Nature
26 publications, 14.69%
Frontiers Media S.A.
19 publications, 10.73%
Wiley
17 publications, 9.6%
Taylor & Francis
5 publications, 2.82%
Hindawi Limited
3 publications, 1.69%
American Association for Cancer Research (AACR)
3 publications, 1.69%
Cold Spring Harbor Laboratory
3 publications, 1.69%
Spandidos Publications
3 publications, 1.69%
Walter de Gruyter
2 publications, 1.13%
AME Publishing Company
2 publications, 1.13%
Pharmaceutical Society of Japan
1 publication, 0.56%
World Scientific
1 publication, 0.56%
SAGE
1 publication, 0.56%
Shenyang Pharmaceutical University
1 publication, 0.56%
Royal Society of Chemistry (RSC)
1 publication, 0.56%
PeerJ
1 publication, 0.56%
American Scientific Publishers
1 publication, 0.56%
Eco-Vector LLC
1 publication, 0.56%
American Society of Hematology
1 publication, 0.56%
Research Square Platform LLC
1 publication, 0.56%
Impact Journals
1 publication, 0.56%
Bentham Science Publishers Ltd.
1 publication, 0.56%
Begell House
1 publication, 0.56%
S. Karger AG
1 publication, 0.56%
American Chemical Society (ACS)
1 publication, 0.56%
Baishideng Publishing Group
1 publication, 0.56%
5
10
15
20
25
30
35
40
45
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
177
Share
Cite this
GOST |
Cite this
GOST Copy
Soleimani A. et al. Role of the NF-κB signaling pathway in the pathogenesis of colorectal cancer // Gene. 2020. Vol. 726. p. 144132.
GOST all authors (up to 50) Copy
Soleimani A., Rahmani F., Ferns G. A., Ryzhikov M., Avan A., Hashemy S. Role of the NF-κB signaling pathway in the pathogenesis of colorectal cancer // Gene. 2020. Vol. 726. p. 144132.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.gene.2019.144132
UR - https://doi.org/10.1016/j.gene.2019.144132
TI - Role of the NF-κB signaling pathway in the pathogenesis of colorectal cancer
T2 - Gene
AU - Soleimani, Atena
AU - Rahmani, Farzad
AU - Ferns, Gordon A
AU - Ryzhikov, Mikhail
AU - Avan, Amir
AU - Hashemy, Seyed Isaac
PY - 2020
DA - 2020/02/01
PB - Elsevier
SP - 144132
VL - 726
PMID - 31669643
SN - 0378-1119
SN - 1879-0038
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2020_Soleimani,
author = {Atena Soleimani and Farzad Rahmani and Gordon A Ferns and Mikhail Ryzhikov and Amir Avan and Seyed Isaac Hashemy},
title = {Role of the NF-κB signaling pathway in the pathogenesis of colorectal cancer},
journal = {Gene},
year = {2020},
volume = {726},
publisher = {Elsevier},
month = {feb},
url = {https://doi.org/10.1016/j.gene.2019.144132},
pages = {144132},
doi = {10.1016/j.gene.2019.144132}
}